Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Insiders & Quasi-insiders

Insiders & Quasi-insiders

posted on Nov 06, 2008 03:48AM

Did I read correctly Leckrone verbally admitted to 2.5 million PTSC shares in his ownership?

So Leckrone has more shares than any of our own company officers?.......

Isn't that kind of embarassing?.......

Share
New Message
Please login to post a reply